Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-07-27

AUTHORS

Kebede Beyene, Wilson Shen, Terry Mitchell, Scott Gilson, Stella Kang, Daniel Lai, Liandra Misquitta, Atifa Slaimankhel, Amy Hai Yan Chan

ABSTRACT

BackgroundOpioid-induced sedation and respiratory depression (OSRD) is a potentially life-threatening side effect of opioid analgesia. However, little is known about the individual and clinical-related factors associated with OSRD in the New Zealand context.AimTo identify risk factors for OSRD in patients admitted to a large regional health board in New Zealand—Auckland District Health Board (ADHB).MethodA retrospective matched case-control study design was undertaken among adults who were admitted to ADHB and prescribed opioids in hospital between August 2015 and April 2020. Those who were prescribed opioids and received naloxone for OSRD were defined as cases, whereas those who received opioids but did not experience OSRD were identified as controls. Cases and controls were matched on a 1:1 basis by age (± 10 years). Data were retrieved from the electronic medical records of ADHB. A conditional logistic regression model was used to identify the risk factors for OSRD.ResultsWe identified 51 cases, and these were matched with 51 control patients. The odds of experiencing OSRD were four times higher among opioid-naïve patients compared to those exposed to opioids prior to hospital admission (OR 4.113; 95% CI 1.14–14.89). Increased risk of OSRD was also associated with higher serum creatinine level prior to OSRD episode (OR 1.015; 95% CI 1.01–1.03) and a higher oral morphine milligram equivalent (OME) (OR 1.023; 95% CI 1.01–1.04).ConclusionIncreased risk of OSRD was associated with a higher OME, a higher serum creatinine level prior to OSRD episode, and opioid naivety. Our findings can inform policies that aim to prevent serious adverse effects related to opioids. More... »

PAGES

1-8

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11096-022-01460-1

DOI

http://dx.doi.org/10.1007/s11096-022-01460-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1149794622

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35896908


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmaceutical and Administrative Sciences, St Louis College of Pharmacy, University of Health Sciences and Pharmacy, 1 Pharmacy Place, 63110, St. Louis, MO, USA", 
          "id": "http://www.grid.ac/institutes/grid.419579.7", 
          "name": [
            "Department of Pharmaceutical and Administrative Sciences, St Louis College of Pharmacy, University of Health Sciences and Pharmacy, 1 Pharmacy Place, 63110, St. Louis, MO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beyene", 
        "givenName": "Kebede", 
        "id": "sg:person.01210444072.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210444072.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pharmacy Department, Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand", 
          "id": "http://www.grid.ac/institutes/grid.414055.1", 
          "name": [
            "Pharmacy Department, Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shen", 
        "givenName": "Wilson", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand", 
          "id": "http://www.grid.ac/institutes/grid.414055.1", 
          "name": [
            "Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mitchell", 
        "givenName": "Terry", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand", 
          "id": "http://www.grid.ac/institutes/grid.9654.e", 
          "name": [
            "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gilson", 
        "givenName": "Scott", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand", 
          "id": "http://www.grid.ac/institutes/grid.9654.e", 
          "name": [
            "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Stella", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand", 
          "id": "http://www.grid.ac/institutes/grid.9654.e", 
          "name": [
            "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lai", 
        "givenName": "Daniel", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand", 
          "id": "http://www.grid.ac/institutes/grid.9654.e", 
          "name": [
            "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Misquitta", 
        "givenName": "Liandra", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand", 
          "id": "http://www.grid.ac/institutes/grid.9654.e", 
          "name": [
            "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Slaimankhel", 
        "givenName": "Atifa", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand", 
          "id": "http://www.grid.ac/institutes/grid.9654.e", 
          "name": [
            "School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chan", 
        "givenName": "Amy Hai Yan", 
        "id": "sg:person.01017667105.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017667105.25"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2022-07-27", 
    "datePublishedReg": "2022-07-27", 
    "description": "BackgroundOpioid-induced sedation and respiratory depression (OSRD) is a potentially life-threatening side effect of opioid analgesia. However, little is known about the individual and clinical-related factors associated with OSRD in the New Zealand context.AimTo identify risk factors for OSRD in patients admitted to a large regional health board in New Zealand\u2014Auckland District Health Board (ADHB).MethodA retrospective matched case-control study design was undertaken among adults who were admitted to ADHB and prescribed opioids in hospital between August 2015 and April 2020. Those who were prescribed opioids and received naloxone for OSRD were defined as cases, whereas those who received opioids but did not experience OSRD were identified as controls. Cases and controls were matched on a\u00a01:1 basis by age (\u00b1\u200910 years). Data were retrieved from the electronic medical records of ADHB. A conditional logistic regression model was used to identify the risk factors for OSRD.ResultsWe identified 51 cases, and these were matched with 51 control patients. The odds of experiencing OSRD were four times higher among opioid-na\u00efve patients compared to those exposed to opioids prior to hospital admission (OR \u20094.113; 95% CI 1.14\u201314.89). Increased risk of OSRD was also associated with higher serum creatinine level prior to OSRD episode (OR 1.015; 95% CI 1.01\u20131.03) and a higher oral morphine milligram equivalent (OME) (OR\u20091.023; 95% CI 1.01\u20131.04).ConclusionIncreased risk of OSRD was associated with a higher OME, a higher serum creatinine level prior to OSRD episode, and opioid naivety. Our findings can inform policies that aim to prevent serious adverse effects related to opioids.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11096-022-01460-1", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1044817", 
        "issn": [
          "2210-7703", 
          "2210-7711"
        ], 
        "name": "International Journal of Clinical Pharmacy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "higher serum creatinine levels", 
      "serum creatinine levels", 
      "risk factors", 
      "creatinine levels", 
      "Health Board", 
      "life-threatening side effects", 
      "conditional logistic regression models", 
      "clinical-related factors", 
      "case-control study design", 
      "serious adverse effects", 
      "case-control study", 
      "District Health Board", 
      "electronic medical records", 
      "logistic regression models", 
      "oral morphine", 
      "opioid toxicity", 
      "naloxone rescue", 
      "respiratory depression", 
      "opioid analgesia", 
      "na\u00efve patients", 
      "control patients", 
      "hospital admission", 
      "medical records", 
      "opioids", 
      "side effects", 
      "regional health boards", 
      "patients", 
      "study design", 
      "adverse effects", 
      "regression models", 
      "adults", 
      "episodes", 
      "risk", 
      "BackgroundOpioids", 
      "analgesia", 
      "sedation", 
      "admission", 
      "morphine", 
      "factors", 
      "AimTo", 
      "hospital", 
      "cases", 
      "ResultsWe", 
      "depression", 
      "odds", 
      "age", 
      "MethodA", 
      "levels", 
      "control", 
      "toxicity", 
      "effect", 
      "findings", 
      "OME", 
      "rescue", 
      "records", 
      "New Zealand context", 
      "study", 
      "data", 
      "time", 
      "equivalent", 
      "board", 
      "AdhB", 
      "naivety", 
      "basis", 
      "model", 
      "design", 
      "context", 
      "OSRD", 
      "policy"
    ], 
    "name": "Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study", 
    "pagination": "1-8", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1149794622"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11096-022-01460-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35896908"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11096-022-01460-1", 
      "https://app.dimensions.ai/details/publication/pub.1149794622"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_931.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11096-022-01460-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01460-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01460-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01460-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01460-1'


 

This table displays all metadata directly associated to this object as RDF triples.

181 TRIPLES      20 PREDICATES      92 URIs      84 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11096-022-01460-1 schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author N43978991f7364e20938504494a1dfbc4
4 schema:datePublished 2022-07-27
5 schema:datePublishedReg 2022-07-27
6 schema:description BackgroundOpioid-induced sedation and respiratory depression (OSRD) is a potentially life-threatening side effect of opioid analgesia. However, little is known about the individual and clinical-related factors associated with OSRD in the New Zealand context.AimTo identify risk factors for OSRD in patients admitted to a large regional health board in New Zealand—Auckland District Health Board (ADHB).MethodA retrospective matched case-control study design was undertaken among adults who were admitted to ADHB and prescribed opioids in hospital between August 2015 and April 2020. Those who were prescribed opioids and received naloxone for OSRD were defined as cases, whereas those who received opioids but did not experience OSRD were identified as controls. Cases and controls were matched on a 1:1 basis by age (± 10 years). Data were retrieved from the electronic medical records of ADHB. A conditional logistic regression model was used to identify the risk factors for OSRD.ResultsWe identified 51 cases, and these were matched with 51 control patients. The odds of experiencing OSRD were four times higher among opioid-naïve patients compared to those exposed to opioids prior to hospital admission (OR  4.113; 95% CI 1.14–14.89). Increased risk of OSRD was also associated with higher serum creatinine level prior to OSRD episode (OR 1.015; 95% CI 1.01–1.03) and a higher oral morphine milligram equivalent (OME) (OR 1.023; 95% CI 1.01–1.04).ConclusionIncreased risk of OSRD was associated with a higher OME, a higher serum creatinine level prior to OSRD episode, and opioid naivety. Our findings can inform policies that aim to prevent serious adverse effects related to opioids.
7 schema:genre article
8 schema:isAccessibleForFree false
9 schema:isPartOf sg:journal.1044817
10 schema:keywords AdhB
11 AimTo
12 BackgroundOpioids
13 District Health Board
14 Health Board
15 MethodA
16 New Zealand context
17 OME
18 OSRD
19 ResultsWe
20 admission
21 adults
22 adverse effects
23 age
24 analgesia
25 basis
26 board
27 case-control study
28 case-control study design
29 cases
30 clinical-related factors
31 conditional logistic regression models
32 context
33 control
34 control patients
35 creatinine levels
36 data
37 depression
38 design
39 effect
40 electronic medical records
41 episodes
42 equivalent
43 factors
44 findings
45 higher serum creatinine levels
46 hospital
47 hospital admission
48 levels
49 life-threatening side effects
50 logistic regression models
51 medical records
52 model
53 morphine
54 naivety
55 naloxone rescue
56 naïve patients
57 odds
58 opioid analgesia
59 opioid toxicity
60 opioids
61 oral morphine
62 patients
63 policy
64 records
65 regional health boards
66 regression models
67 rescue
68 respiratory depression
69 risk
70 risk factors
71 sedation
72 serious adverse effects
73 serum creatinine levels
74 side effects
75 study
76 study design
77 time
78 toxicity
79 schema:name Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study
80 schema:pagination 1-8
81 schema:productId N65230f7af1b54c70b9f959b9b200837c
82 Nea0ea1663ef2460d924cb9d6224c0898
83 Nf7ef8d041a364ab8863a141e153ab64d
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1149794622
85 https://doi.org/10.1007/s11096-022-01460-1
86 schema:sdDatePublished 2022-12-01T06:44
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher N2cd5d92514084ecfaea1e3a2fe9e21d4
89 schema:url https://doi.org/10.1007/s11096-022-01460-1
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N0bdd1b1332b24149956c43c04c7b008d schema:affiliation grid-institutes:grid.414055.1
94 schema:familyName Shen
95 schema:givenName Wilson
96 rdf:type schema:Person
97 N12819359ed0a4ff29e11719d96b48e31 schema:affiliation grid-institutes:grid.9654.e
98 schema:familyName Gilson
99 schema:givenName Scott
100 rdf:type schema:Person
101 N1ea5d2979b0b42fbad84c095a174730f schema:affiliation grid-institutes:grid.9654.e
102 schema:familyName Misquitta
103 schema:givenName Liandra
104 rdf:type schema:Person
105 N2cd5d92514084ecfaea1e3a2fe9e21d4 schema:name Springer Nature - SN SciGraph project
106 rdf:type schema:Organization
107 N43978991f7364e20938504494a1dfbc4 rdf:first sg:person.01210444072.17
108 rdf:rest N605ace3796e54f2d8f8a74d78e737ebc
109 N605ace3796e54f2d8f8a74d78e737ebc rdf:first N0bdd1b1332b24149956c43c04c7b008d
110 rdf:rest N9d38f7daf57c4e88af33b11bbd71cd96
111 N65230f7af1b54c70b9f959b9b200837c schema:name doi
112 schema:value 10.1007/s11096-022-01460-1
113 rdf:type schema:PropertyValue
114 N69b02f67f7084102b9f2af4653754485 schema:affiliation grid-institutes:grid.9654.e
115 schema:familyName Kang
116 schema:givenName Stella
117 rdf:type schema:Person
118 N70c25edc1e744880a335dbdcc8f412d0 rdf:first N69b02f67f7084102b9f2af4653754485
119 rdf:rest Ncc10e4e3021c45999dab92411b34b0c9
120 N7ce4de29b5144c42b4ff74319316b109 rdf:first sg:person.01017667105.25
121 rdf:rest rdf:nil
122 N9a7bc1314adf4fe79e8d6d739d51ee61 rdf:first N12819359ed0a4ff29e11719d96b48e31
123 rdf:rest N70c25edc1e744880a335dbdcc8f412d0
124 N9d38f7daf57c4e88af33b11bbd71cd96 rdf:first Nd037ab145d4e42e28adfdf9048ff4709
125 rdf:rest N9a7bc1314adf4fe79e8d6d739d51ee61
126 Nb645cea4b86b4d6da004e74fe7b200c9 rdf:first Nc313505e66504f46b7eaab6084273882
127 rdf:rest N7ce4de29b5144c42b4ff74319316b109
128 Nc313505e66504f46b7eaab6084273882 schema:affiliation grid-institutes:grid.9654.e
129 schema:familyName Slaimankhel
130 schema:givenName Atifa
131 rdf:type schema:Person
132 Nc60233018b0648c297ead6b39e56615d rdf:first N1ea5d2979b0b42fbad84c095a174730f
133 rdf:rest Nb645cea4b86b4d6da004e74fe7b200c9
134 Nc99bade9add64732a920d8212cb234b7 schema:affiliation grid-institutes:grid.9654.e
135 schema:familyName Lai
136 schema:givenName Daniel
137 rdf:type schema:Person
138 Ncc10e4e3021c45999dab92411b34b0c9 rdf:first Nc99bade9add64732a920d8212cb234b7
139 rdf:rest Nc60233018b0648c297ead6b39e56615d
140 Nd037ab145d4e42e28adfdf9048ff4709 schema:affiliation grid-institutes:grid.414055.1
141 schema:familyName Mitchell
142 schema:givenName Terry
143 rdf:type schema:Person
144 Nea0ea1663ef2460d924cb9d6224c0898 schema:name pubmed_id
145 schema:value 35896908
146 rdf:type schema:PropertyValue
147 Nf7ef8d041a364ab8863a141e153ab64d schema:name dimensions_id
148 schema:value pub.1149794622
149 rdf:type schema:PropertyValue
150 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
151 schema:name Medical and Health Sciences
152 rdf:type schema:DefinedTerm
153 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
154 schema:name Public Health and Health Services
155 rdf:type schema:DefinedTerm
156 sg:journal.1044817 schema:issn 2210-7703
157 2210-7711
158 schema:name International Journal of Clinical Pharmacy
159 schema:publisher Springer Nature
160 rdf:type schema:Periodical
161 sg:person.01017667105.25 schema:affiliation grid-institutes:grid.9654.e
162 schema:familyName Chan
163 schema:givenName Amy Hai Yan
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017667105.25
165 rdf:type schema:Person
166 sg:person.01210444072.17 schema:affiliation grid-institutes:grid.419579.7
167 schema:familyName Beyene
168 schema:givenName Kebede
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210444072.17
170 rdf:type schema:Person
171 grid-institutes:grid.414055.1 schema:alternateName Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand
172 Pharmacy Department, Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand
173 schema:name Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand
174 Pharmacy Department, Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand
175 rdf:type schema:Organization
176 grid-institutes:grid.419579.7 schema:alternateName Department of Pharmaceutical and Administrative Sciences, St Louis College of Pharmacy, University of Health Sciences and Pharmacy, 1 Pharmacy Place, 63110, St. Louis, MO, USA
177 schema:name Department of Pharmaceutical and Administrative Sciences, St Louis College of Pharmacy, University of Health Sciences and Pharmacy, 1 Pharmacy Place, 63110, St. Louis, MO, USA
178 rdf:type schema:Organization
179 grid-institutes:grid.9654.e schema:alternateName School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
180 schema:name School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
181 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...